Navigation Links
GranuFlo Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal GranuFlo Recall Litigation
Date:8/21/2013

New York, New York (PRWEB) August 21, 2013

GranuFlo lawsuits (http://www.granuflodialysislawsuits.com/) filed in the wake of last year’s recall for GranuFlo and NaturaLyte dialysis drugs continue to mount in the federal multidistrict litigation now underway in U.S. District Court, District of Massachusetts. Court documents indicate that the proceeding’s initial Status Conference will be convened on August 30, 2013 at 9:30 a.m. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)

“We continue to hear from alleged victims of the GranuFlo recall on a regular basis. We look forward to this conference, and additional progress in the litigation over the coming months,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free GranuFlo lawsuit evaluations to dialysis patients who may have been harmed by GranuFlo or NaturaLyte.

GranFlo Recall
Last year, the U.S. Food & Drug Administration (FDA) announced a Class I GranuFlo recall, after Fresenius Medical Care issued an “Urgent Product Notification” in March 2012 to its customer clinics warning of possible heart risks associated with GranuFlo and NaturaLyte. Both drugs are administered during dialysis to reduce acid in the blood. According to the Urgent Product Notification, both had been associated with high levels of bicarbonate in the blood, which can lead to metabolic alkalosis, a significant risk factor for serious and potentially deadly cardiovascular problems, including low blood pressure, cardiac arrhythmia, cardiopulmonary arrest, and sudden cardiac death.

The New York Times reported last summer that the FDA had launched an investigation of Fresenius Medical Care’s handling of the GranuFlo recall, after learning that the company had issued a memo in November 2011 to its own clinics that warned of the heart risks associated with GranuFlo and NaturaLyte. However, clinics outside of the Fresenius network did not receive a similar warning until March 2012.*

Court documents indicate that more than 300 GranuFlo lawsuits are now pending in the District of Massachusetts. Plaintiffs allege that Fresenius Medical Care knew or should have known of the propensity of GranuFlo and NaturaLyte to cause injury. They also accuse the company of failing to provide adequate warnings regarding their use, and assert that Fresenius continued to aggressively market the products even after the company became aware of their dangers.

Dialysis patients who suffered heart attacks, sudden cardiac death, and other catastrophic heart side effects within 48 hours of a dialysis treatment with GranuFlo or NaturaLyte may be entitled to file a Granuflo lawsuit to obtain compensation for medical expenses, lost wages, pain and suffering, and more. Learn More about the GranuFlo recall by visiting Bernstein Liebhard LLP’s website. For additional information, please call 800-511-5092.

*nytimes.com/2012/06/15/health/fda-investigates-fresenius-for-failure-to-warn-of-risk.html; New York Times, June 14, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.granuflodialysislawsuits.com/

Read the full story at http://www.prweb.com/releases/granuflo-lawsuit/granuflo-recall/prweb11049474.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NaturaLyte and GranuFlo Lawsuits Are Heating Up
2. New Fresenius NaturaLyte, GranuFlo Dialysis Heart Attack Lawsuit Allegations Update: Resource4thePeople Reports Important Hearing Is Scheduled in Fresenius Multidistrict Litigation
3. Rottenstein Law Group LLP Announces Launch of GranuFlo Lawsuit Center
4. GranuFlo Recall Lawyers at Wright & Schulte LLC Investigating GranuFlo Lawsuits on Behalf of Dialysis Patients Allegedly Injured by GanuFlo or NaturaLyte
5. Granuflo Multidistrict Litigation Moves Forward: Now, AttorneyOne Can Provide Advice
6. GranuFlo Lawsuit News: W.Va. Man’s Lawsuit Goes to Federal Court, Rottenstein Law Group LLP Reports
7. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard Notes Issuance of New Order in Federal GranuFlo Recall Litigation
8. GranuFlo Lawsuits Moving Forward in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
9. Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama
10. GranuFlo Lawsuit News: Bernstein Liebhard LLP Reports on Growing Litigation Surrounding GranuFlo Recall
11. New Granuflo Cardiac Arrest Lawsuit: Now, AttorneyOne Can Provide Advice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has written a new ... the Bible about helping to stop cancer. Yisrayl says there are too many suffering and ... health and science industries will pay close attention and take action. The Pastor says that ...
(Date:5/6/2016)... ... 06, 2016 , ... In honor of Military Spouse Appreciation ... and the National Military Family Association, a nonprofit that works to strengthen and ... scholarship recipient of 2016. , “Being awarded this scholarship by Career Step, ...
(Date:5/6/2016)... ... 06, 2016 , ... Kenneth Cochran, DSc, RN, FACHE, President/CEO ... the South announced today that Dr. Robert Menuet, Interventional Cardiologist with Cardiovascular Institute ... Guided Coronary Atherectomy. , This procedure involves the removal of plaque ...
(Date:5/6/2016)... ... May 06, 2016 , ... RowdMap, ... Blue Cross BlueShield and Former Principal Deputy Administrator at Centers for Medicare and ... Company; Steve Ondra, MD, Chief Medical Officer at Health Care Service Corporation (Blue ...
(Date:5/5/2016)... , ... May 05, 2016 , ... While the practice ... paid to the impact our aging population has on communities and resources. Aging Life ... plan for and face age-related challenges. , Aging Life Care is a holistic, ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... May 5, 2016  Diagnostic imaging has been ... to concerns that these tests cause health care costs to ... imaging, as well as the adoption of new ... medical peripherals that help health care providers cut costs, while ... medical imaging is a renowned authorized reseller of the ...
(Date:5/5/2016)... 5, 2016 Research ... "Europe Thalassaemia Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... and Competitive Landscape Highlights - 2016, provides ... epidemiology, Thalassaemia market valuations and forecast, Thalassaemia ...
(Date:5/4/2016)... NESS ZIONA, Israel , May ... BVXV, TASE: BVXV) announced today that BiondVax,s CEO, Dr. ... 2016 conference in New York City . ... presenting at 10:30am at Pioneers 2016, a conference presented by ... New York Palace Hotel. The BiondVax presentation that ...
Breaking Medicine Technology: